Elekta and its global collaborators overcame significant engineering hurdles to demonstrate the technology’s feasibility. Previously, experts in the field thought it nearly impossible to combine MRI ...
Zacks Investment Research on MSN
Elekta wins FDA nod for Evo CT-Linac, boosting US radiation oncology
Elekta EKTAY recently announced that its Elekta Evo CT-Linac has received 510(k) clearance from the FDA, making the system available to radiation oncology professionals across the United States. Evo ...
In order to deliver Adaptive Radiation Therapy (ART) for cancer, Elekta, a global leader in precision radiation therapy, will launch an advanced AI-enabled CT-Linac (linear accelerator) by the name ...
The FINANCIAL — Elekta (EKTA-B.ST), Royal Philips and The Netherlands Cancer Institute, (NKI, Amsterdam, the Netherlands) on April 17 announced the installation of a high-field (1.5 Tesla) MR-guided ...
GUWAHATI, India, Dec. 5, 2025 /PRNewswire/ -- Elekta announced the introduction of its latest linear accelerator (linac), Evo*, to the Indian market. Already launched in Europe and other regions, Evo ...
ATLANTA - Elekta (EKTA-B.ST) announced that its Elekta Evo* CT-Linac has today received 510(k) clearance from the U.S. Food and Drug Administration (FDA). This milestone makes the system available to ...
ATLANTA — With much pomp and circumstance, Elekta (Stockholm, Sweden) unveiled its Versa HD, an advanced linear accelerator system designed to improve patient care and treat a broader spectrum of ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果